OSSOLI, ALICE FEDERICA
OSSOLI, ALICE FEDERICA
Dipartimento di Scienze Farmacologiche e Biomolecolari
Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation
2019-12-30 R. Scicali, A. Di Pino, C. Pavanello, A. Ossoli, A. Strazzella, A. Alberti, S. Di Mauro, A. Scamporrino, F. Urbano, A. Filippello, S. Piro, A.M. Rabuazzo, L. Calabresi, F. Purrello
Anti-atherosclerotic effect of a polyphenol-rich ingredient, oleactiv®, in a hypercholesterolemia-induced golden syrian hamster model
2018-10-15 C. Romain, A. Piemontese, S. Battista, F. Bernini, A. Ossoli, A. Strazzella, S. Gaillet, J.M. Rouanet, J. Cases, I. Zanotti
Complete and Partial LCAT Deficiency are Differentially Associated with Atherosclerosis
2018-09-04 F. Oldoni, D. Baldassarre, S. Castelnuovo, A. Ossoli, M. Amato, J. van Capelleveen, G.K. Hovingh, E. de Groot, A. Bochem, S. Simonelli, S. Barbieri, F. Veglia, G. Franceschini, J.A. Kuivenhoven, A.G. Holleboom, L. Calabresi
Deficit di lecitina:colesterolo aciltransferasi: dalla genetica alla terapia
2016-01-01 F. Lucca, A. Ossoli, G. Boscutti, G. Franceschini, L. Calabresi
Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiency
2017-01-01 M. Gomaraschi, A. Ossoli, S. Castelnuovo, S. Simonelli, C. Pavenello, G. Balzarotti, M. Arca, A. Di Costanzo, T. Sampietro, G. Vaudo, D. Baldassarre, F. Veglia, G. Franceschini, L. Calabresi
Dysfunctional HDL as a therapeutic target for atherosclerosis prevention
2019-03-01 A. Ossoli, C. Pavanello, E. Giorgio, L. Calabresi, M. Gomaraschi
Effects of multiple infusions of recombinant LCAT on plasma and tissue lipids and expression of genes involved in atherogenesis
2013-01-01 B.V.X. Rousset, B.J. Auerbach, B.R. Krause, R. Homan, L. Freeman, A. Ossoli, M.L.S. Lsampson, A.T. Remaley
eNOS activation by HDL is impaired in genetic CETP deficiency
2014-05-15 M. Gomaraschi, A. Ossoli, S. Pozzi, P. Nilsson, A.B. Cefalù, M. Averna, J.A. Kuivenhoven, G..K. Hovingh, F. Veglia, G. Franceschini, L. Calabresi
Fenofibrate and extended-release niacin improve the endothelial protective effects of HDL in patients with metabolic syndrome
2015-11-01 M. Gomaraschi, A. Ossoli, M.P. Adorni, E. Damonte, E. Niesor, F. Veglia, G. Franceschini, R. Benghozi, L. Calabresi
HDL and endothelial protection : examining evidence from HDL inherited disorders
2013-06-01 M. Gomaraschi, A. Ossoli, C. Vitali, L. Calabresi
Hepatic ACAT2 knock down increases ABCA1 and modifies HDL metabolism in mice
2014-01-01 M. Pedrelli, P. Davoodpour, C. Degirolamo, M. Gomaraschi, M. Graham, A. Ossoli, L. Larsson, L. Calabresi, J. Gustafsson, K.R. Steffensen, M. Eriksson, P. Parini
High-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and Atherosclerosis
2016-06-01 A. Ossoli, C. Pavanello, L. Calabresi
Il trattamento con topiramato protegge i topi APOE-KO dall’insorgenza di danno renale senza modificare i livelli dei lipidi plasmatici
2019-01-01 M. Busnelli, S. Manzini, C. Parolini, L. Minoli, A. Ossoli, S. Simonelli, E. Brambilla, E. Lekka, A. Persidis, E. Scanziani, G. Chiesa
Intracoronary monocyte expression pattern and HDL subfractions after non-ST elevation myocardial infarction
2021-06-01 M. Cariello, R. Salvia, J. Härdfeldt, M. Piglionica, D. Rutigliano, P. Caldarola, A. Ossoli, M. Vacca, G. Graziano, S. Battaglia, R. Zerlotin, M. Arconzo, L. Crudele, C. Sabbà, L. Calabresi, A. Moschetta
Le lipoproteine ad alta densità: uno strumento polivalente contro il cancro?
2021-01-01 A. Ossoli, M. Gomaraschi
Lecithin:cholesterol acyltransferase activation by sulfhydryl-reactive small molecules: Role of cysteine-31
2017-08-01 L.A. Freeman, S. J. Demosky Jr., M. Konaklieva, R. Kuskovsky, A. Aponte, A.F. Ossoli, S.M. Gordon, R.F. Koby, K.A. Manthei, M. Shen, B.L. Vaisman, R.D. Shamburek, A. Jadhav, L. Calabresi, M. Gucek, J.J.G. Tesmer, R.L. Levine, A.T. Remaley
LIPA gene mutations affect the composition of lipoproteins: Enrichment in ACAT-derived cholesteryl esters
2020-03-01 L. Arnaboldi, A.F. Ossoli, E. Giorgio, L. Pisciotta, T. Lucchi, L. Grigore, C. Pavanello, A.C. Granata, A. Pasta, B. Arosio, D. Azzolino, A. Baragetti, S. Castelnuovo, A. Corsini, A.L. Catapano, L. Calabresi, M. Gomaraschi
Lipoprotein X causes renal disease in LCAT deficiency
2016-02-26 A. Ossoli, E.B. Neufeld, S.G. Thacker, B. Vaisman, M. Pryor, L.A. Freeman, C.A. Brantner, I. Baranova, N.O. Francone, S.J. Demosky, C. Vitali, M. Locatelli, M. Abbate, C. Zoja, G. Franceschini, L. Calabresi, A.T. Remaley
Low Plasma Lecithin : Cholesterol Acyltransferase (LCAT) Concentration Predicts Chronic Kidney Disease
2020-07-18 A. Baragetti, A. Ossoli, A. Strazzella, S. Simonelli, I. Baragetti, L. Grigore, F. Pellegatta, A. Catapano, G. Norata, L. Calabresi
Matrix metalloproteinase-2 on activated platelets triggers endothelial PAR-1 initiating atherosclerosis
2022-02-10 S. Momi, E. Falcinelli, E. Petito, G. Ciarrocca Taranta, A. Ossoli, P. Gresele